Comparative effectiveness of dimethyl fumarate as the initial and secondary treatment for MS.

Mathias GranqvistJoachim BurmanMartin GunnarssonJan LyckePetra NilssonTomas OlssonPeter SundströmAnders SvenningssonMagnus VrethemThomas FrisellFredrik Piehl

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2019)

Our findings indicate that DMF performs better than IFN/GA as the initial treatment for RRMS. Compared to FGL, DMF displayed a lower tolerability, but largely similar effectiveness outcomes.

Keyphrases

randomized controlled trial
systematic review
multiple sclerosis
immune response
mass spectrometry
type diabetes
ms ms
clinical trial
adipose tissue
combination therapy
replacement therapy
weight loss